Terms of Use
This website provides information about ATTR-CM (transthyretin amyloid cardiomyopathy).
This website is operated by Bayer. By accessing or using this website, users acknowledge and agree to be bound by these Terms of Use. Bayer reserves the right to amend these Terms of Use at any time. Users are advised to review this page periodically to remain informed of any changes.
Purpose of this website
This website provides general information about ATTR-CM and related topics. The content is intended to inform and support patients, caregivers, family members and other interested persons.
The information provided on this website is for general informational purposes only and shall not be construed as medical advice, diagnosis or treatment.
Medical information
Although Bayer uses reasonable efforts to ensure that the information on this website is accurate and up to date, Bayer makes no representations or warranties, whether express or implied, as to the completeness, accuracy or timeliness of such information.
The information on this website is not intended to replace professional medical advice, diagnosis or treatment.
Users who have questions concerning ATTR-CM, their health condition, symptoms or treatment should consult their physician, specialist or another qualified healthcare professional. Users should never disregard professional medical advice or delay seeking such advice because of information obtained through this website.
Reporting side effects or product complaints
This website is not intended to be used for reporting adverse events, product quality complaints or other safety-related information concerning medicinal products.
If users suspect that they are experiencing an adverse event associated with a medicinal product, they should contact their physician, pharmacist or another qualified healthcare professional. Adverse events may also be reported through the designated reporting channels of the competent health authorities or to Bayer.
Where a possible adverse event or product complaint is reported to Bayer, Bayer may be legally required to record, assess, investigate and, where applicable, report such information to the competent authorities. In this context, Bayer may contact the reporting person to request additional information.
Personal data processed in connection with pharmacovigilance activities will be handled in accordance with applicable data protection laws and Bayer’s Privacy Statement.
Intellectual property
All text, images, logos, videos and other content made available on this website are owned by Bayer or used with the permission of the respective rights holders, unless expressly stated otherwise.
Users may access, view and download information from this website solely for personal, non-commercial use. No content from this website may be copied, modified, distributed, published, reproduced or used for commercial purposes without Bayer’s prior written consent.
All trademarks, logos and trade names displayed on this website are the property of Bayer or the relevant rights holders and may not be used without prior authorization.
Liability
Bayer uses reasonable efforts to maintain the information on this website in an accurate and up-to-date manner. Nevertheless, errors, inaccuracies or omissions may occur.
To the fullest extent permitted by applicable law, Bayer shall not be liable for any loss or damage arising out of or in connection with access to, use of, inability to use, or reliance on any information provided through this website.
Nothing in these Terms of Use shall exclude or limit any liability that cannot be excluded or limited under applicable law.
Links to other websites
This website may contain links or references to websites operated by third parties. Such links are provided solely for convenience and informational purposes.
Bayer does not control, and is not responsible for, the content, availability, accuracy, security or privacy practices of third-party websites and does not endorse such websites or their content.
Access to and use of third-party websites is at the user’s own risk.
Privacy and data protection
Bayer attaches great importance to the protection of personal data and processes personal data in a careful and lawful manner.
When users access or use this website, certain personal data may be collected and processed, including where users contact Bayer or use specific website functions.
Bayer processes personal data only in accordance with applicable data protection legislation.
Bayer’s Privacy Statement provides further information, including but not limited to:
- the categories of personal data collected;
- the purposes for which such data is processed;
- the applicable legal bases for the processing;
- the applicable retention periods;
- the recipients or categories of recipients with whom personal data may be shared;
- the rights available to users in relation to their personal data.
Subject to applicable legal requirements and limitations, users may have rights of access, rectification, erasure, restriction of processing, data portability and objection. Users may also have the right to lodge a complaint with the competent supervisory authority.
Further information is available in Bayer’s Privacy Statement.
Information you provide
Where users submit information to Bayer through forms or other contact options made available on this website, users are responsible for ensuring that such information is accurate, complete and lawful.
Any personal data submitted by users will be processed in accordance with Bayer’s Privacy Statement and applicable data protection legislation.
Changes
Bayer reserves the right, at its sole discretion and without prior notice, to modify, supplement, suspend or discontinue this website, its content or these Terms of Use, in whole or in part, at any time.
Applicable law
These Terms of Use shall be governed by and construed in accordance with the laws of Germany, to the extent permitted by applicable law.
If any provision of these Terms of Use is held to be invalid, unlawful or unenforceable, the validity and enforceability of the remaining provisions shall not be affected.